The Medicines Company (NASDAQ: MDCO)
Rowley Law PLLC is investigating potential securities law violations by The Medicines Company (NASDAQ: MDCO) and its board of directors concerning the proposed acquisition of the company by Novartis AG (NYSE: NVS). Stockholders will receive $85.00 for each share of The Medicines Company stock that they hold. The transaction is valued at approximately $9.7 billion […]